Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han-Yue Qiu

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|June 8, 2021
A patent review of mTOR inhibitors for cancer therapy (2011-2020)Han-Yue Qiu, Peng-Fei Wang, Min Zhang
Expert Opinion on Therapeutic Patents|July 9, 2019
A patent review of BRAF inhibitors: 2013-2018Peng-Fei Wang, Han-Yue Qiu, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|September 18, 2020
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 - 2019)Peng-Fei Wang, Han-Yue Qiu, Yun He, et al.
Current Topics in Medicinal Chemistry|May 13, 2021
Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold ResearchHan-Yue Qiu, Rasmus Praetorius Clausen, Yun He, et al.
Expert Opinion on Therapeutic Patents|November 24, 2022
An updated patent review of IDO1 inhibitors for cancer (2018-2022)Peng-Fei Wang, Li-Qiang Yang, Zhao-Hang Shi, et al.
Fish & Shellfish Immunology|September 4, 2017
Exploring gene expression changes in the amphioxus gill after poly(I:C) challenge using digital expression profilingQi-Lin Zhang, Han-Yue Qiu, Ming-Zhong Liang, et al.
Chemical Biology & Drug Design|June 11, 2015
Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 InhibitorsPeng-Fei Wang, Han-Yue Qiu, Shahla Karim Baloch, et al.
Chemical Biology & Drug Design|November 14, 2017
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agentsHan-Yue Qiu, Peng-Fei Wang, Hong-Yan Lin, et al.
Pharmacological Research|January 3, 2016
Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibitionHan-Yue Qiu, Peng-Fei Wang, Zhen Li, et al.
Chemmedchem|October 25, 2018
Identification and Biological Evaluation of Novel Type II B-Raf<sup>V600E</sup> InhibitorsPeng-Fei Wang, Ze-Feng Wang, Han-Yue Qiu, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|June 8, 2021
A patent review of mTOR inhibitors for cancer therapy (2011-2020)Han-Yue Qiu, Peng-Fei Wang, Min Zhang
Expert Opinion on Therapeutic Patents|July 9, 2019
A patent review of BRAF inhibitors: 2013-2018Peng-Fei Wang, Han-Yue Qiu, Hai-Liang Zhu
Expert Opinion on Therapeutic Patents|September 18, 2020
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 - 2019)Peng-Fei Wang, Han-Yue Qiu, Yun He, et al.
Current Topics in Medicinal Chemistry|May 13, 2021
Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold ResearchHan-Yue Qiu, Rasmus Praetorius Clausen, Yun He, et al.
Expert Opinion on Therapeutic Patents|November 24, 2022
An updated patent review of IDO1 inhibitors for cancer (2018-2022)Peng-Fei Wang, Li-Qiang Yang, Zhao-Hang Shi, et al.
Fish & Shellfish Immunology|September 4, 2017
Exploring gene expression changes in the amphioxus gill after poly(I:C) challenge using digital expression profilingQi-Lin Zhang, Han-Yue Qiu, Ming-Zhong Liang, et al.
Chemical Biology & Drug Design|June 11, 2015
Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 InhibitorsPeng-Fei Wang, Han-Yue Qiu, Shahla Karim Baloch, et al.
Chemical Biology & Drug Design|November 14, 2017
Naphthoquinones: A continuing source for discovery of therapeutic antineoplastic agentsHan-Yue Qiu, Peng-Fei Wang, Hong-Yan Lin, et al.
Pharmacological Research|January 3, 2016
Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibitionHan-Yue Qiu, Peng-Fei Wang, Zhen Li, et al.
Chemmedchem|October 25, 2018
Identification and Biological Evaluation of Novel Type II B-Raf<sup>V600E</sup> InhibitorsPeng-Fei Wang, Ze-Feng Wang, Han-Yue Qiu, et al.
Pageof 3